Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 131 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1301 9.3 months Metastatic melanoma 4 Chemotherapy
Aix-Marseille University France 7/2014
Treatment Details: Patients: This phase 2 study involved metastatic melanoma patients who were divided into two separate treatment groups. Group A consisted of 168 patients with a median age of 60 years; 61.
 
1302 9.3 months EGFR-positive, KRAS-mutant, advanced colorectal cancer 4 Biologic therapy
Institut Gustave Roussy France 2/2014
Treatment Details: Patients: This study involved 25 EGFR-positive, KRAS-mutant, advanced colorectal cancer patients who had been previously treated. The median patient age was 63 years and 56% were male.
 
1303 9.3 months Hepatocellular carcinoma 4 Biologic therapy
Kantonsspital St. Gallen Switzerland 3/2010
Treatment Details: Patients: This phase II study involved 45 hepatocellular carcinoma patients who had not received prior systemic treatment. The median age was 63 years and 87% were male. Treatment: Pat
 
1304 9.3 months Advanced urothelial cancer 5 Chemotherapy
Kaiser Franz Josef Hospital Austria 1/2012
Treatment Details: Patients: This study involved advanced urothelial cancer patients who had not received prior chemotherapy. Patients were divided into two separate treatment groups. Group A included 119 p
 
1305 9.3 months Malignant Pleural Mesothelioma 4 Chemotherapy
Immunotherapy
Istituto Clinico Humanitas Italy 8/2001
Treatment Details: Patients: This Phase II study involved 37 patients with malignant pleural mesothelioma who had not received chemotherapy or biological therapy before. Treatment: The treatment consisted o
 
1306 9.3 months Malignant Pleural Mesothelioma 4 Alternative
Chemotherapy
University of Chicago, Cancer Research Center United States 7/2003
Treatment Details: Patients: This Phase III study involved a total of 448 patients with malignant pleural mesothelioma. Patients were divided into two groups. Group A was comprised of 226 patients and Group
 
1307 9.3 months Newly diagnosed GBM 4 Chemotherapy
Radiation
London Regional Cancer Centre Canada 7/2002
Treatment Details: Patients: This Phase II trial included 87 patients with glioblastoma multiforme. (84 patients were considered assessable.) Treatment: Treatment consisted of standard cranial radiation th
 
1308 9.3 months Newly diagnosed high grade glioma 3 Biologic therapy
Radiation
Hoag Cancer Center United States 1/2001
Treatment Details: Patients: A total of 40 patients comprised of 36 patients with glioblastoma multiforme (or grade 4 anaplastic astrocytoma), and 4 patients with grade 3 anaplastic astrocytoma. Treatment:
 
1309 9.3 months Newly diagnosed GBM 5 Chemotherapy
Radiation
Emory University United States 4/2000
Treatment Details: Patients: This Phase II study involved 47 patients with newly diagnosed glioblastoma multiforme. Treatment: Treatment consisted of the administration of two chemotherapy drugs, BCNU and
 
1310 9.3 months MPM 5 Chemotherapy
University of Chicago United States 6/2005
Treatment Details: Patients: This Phase II study involved 28 patients with malignant mesothelioma. Eighteen patients were men, and ten were women. The median age was 66 years. Twenty patients had been expos
 
Page 131 of 187  | Previous Page  | Next Page